Differential contribution of Bacillus anthracis toxins to pathogenicity in two animal models

Infection and Immunity

Volumn 80, Issue 8, 2012, Pages 2623-2631

  Levy, Haim ^a   Weiss, Shay ^a   Altboum, Zeev ^a   Schlomovitz, Josef ^a   Glinert, Itai ^a   Sittner, Assa ^a   Shafferman, Avigdor ^a   Kobiler, David ^a  

^a ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BACTERIAL TOXIN; PROTEIN CYA; PROTEIN LEF; PROTEIN PAG; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL GENE; BACTERIAL VIRULENCE; FEMALE; GENE DELETION; GUINEA PIG; LETHAL GENE; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; RABBIT; RESPIRATORY TRACT INFECTION;

ANIMALS; ANTHRAX; ANTIGENS, BACTERIAL; BACILLUS ANTHRACIS; BACTERIAL PROTEINS; BACTERIAL TOXINS; DISEASE MODELS, ANIMAL; DNA, BACTERIAL; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION, BACTERIAL; GENOTYPE; GUINEA PIGS; POLYMERASE CHAIN REACTION; RABBITS; VIRULENCE;

EID: 84864827884     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00244-12     Document Type: Article

References (42)

1. Ariel N, et al. 2002. Search for potential vaccine candidate open reading frame in the Bacillus anthracis virulence plasmid pXO1: in silico and in vitro screening. Infect. Immun. 7:6817- 6827.
2. Bourgogne A, Drysdale M, Hilsenbeck SG, Peterson SN, Koehler TM. 2003. Global effects of virulence gene regulators in a Bacillus anthracis strain with both virulence plasmids. Infect. Immun. 71:2736 -2743.
3. Chand HS, et al. 2009. Discriminating virulence mechanisms among Bacillus anthracis strains by using a murine subcutaneous infection model. Infect. Immun. 77:429-435.
4. Chitlaru T, Altboum Z, Reuveny S, Shafferman A. 2011. Progress and novel strategies in vaccine development and treatment of anthrax. Immunol. Rev. 239:221-234.
5. Chitlaru T, et al. 2011. HtrA is a major virulence determinant of Bacillus anthracis. Mol. Microbiol. 81:1542-1559.
6. Chitlaru T, Gat O, Gozlan Y, Ariel N, Shafferman A. 2006. Differential proteomic analysis of the Bacillus anthracis secretome: distinct plasmid and chromosome CO2 dependent cross talk mechanisms modulate extracellular proteolytic activities. J. Bacteriol. 188:3551-3771.
7. Chitlaru T, et al. 2007. Identification of in vivo-expressed immunogenic proteins by serological proteome analysis of the bacillus anthracis secretome. Infect. Immun. 75:2841-2846.
8. Chitlaru T, Shafferman A. 2009. Proteomic studies of Bacillus anthracis. Future Microbiol. 4:983-998.
9. Cohen S, et al. 2000. Attenuated nontoxinogenic and nonencapsulated recombinant Bacillus anthracis spore vaccines protect against anthrax. Infect. Immun. 68:4549-4558.
10. Collier RJ. 2009. Membrane translocation by anthrax toxin. Mol. Aspects Med. 30:413- 422.
11. Dumetz F, et al. 2011. Noninvasive imaging technologies reveal edema toxin as key virulence factor in anthrax. Biophys. Imaging Comput. Biol. 178:2523-2535.
12. Ebrahimi CM, Sheen TR, Renken CW, Gottlieb RA, Doran K. 2011. Contribution of lethal toxin and edema toxin to the pathogenesis of anthrax meningitis. Infect. Immun. 79:2510 -2518.
13. FDA. 16 November 2010. Pathway to licensure for protective antigen-based anthrax vaccines for post-exposure prophylaxis indication using the animal rule. http://www.fda.gov/downloads/advisorycommittees/committeesmeetingmaterials/bloodvaccinesandotherbiologics/vaccinesandrelatedbiologiclproductsadvisorycommittee/ucm232400.pdf.
14. Fellows PF, et al. 2001. Efficacy of a human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin. Vaccine 19:3241-3247.
15. Firoved AM, et al. 2005. Bacillus anthracis edema toxin causes extensive tissue lesions and rapid lethality in mice. Am. J. Pathol. 167:1309 -1320.
16. Gat O, et al. 2006. Search for Bacillus anthracis potential vaccine candidates by a functional genomic serologic screen. Infect. Immun. 74:3987- 4003.
17. Gat O, et al. 2005. The solute-binding component of a putative Mn(II) ABC transporter (MntA) is a novel Bacillus anthracis virulence determinant. Mol. Microbiol. 58:533-551.
18. Goossens PL. 2009. Animal models of human anthrax: the quest for the holy grail. Mol. Aspects Med. 30:467- 480.
19. Guichard A, McGillivivray SM, Cruz-Moreno B, van Sorge NM, Bier E. 2010. Anthrax toxins cooperatively inhibit endocytic recycling by the Rab11/Sec15 exocyst. Nature 467:854-859.
20. Ivins BE, et al. 1986. Immunization studies with attenuated strains of Bacillus anthracis. Infect. Immun. 52:454-458.
21. Janes BK, Stibitz S. 2006. Routine markerless gene replacement in bacillus anthracis. Infect. Immun. 74:1949 -1953.
22. Jenkins A, et al. 2011. Role of purine biosynthesis in Bacillus anthracis pathogenesis and virulence. Infect. Immun. 79:153-166.
23. Kobiler D, et al. 2002. Efficiency of protection of guinea pigs against infection with Bacillus anthracis spores by passive immunization. Infect. Immun. 70:544 -560.
24. Levy H, Fisher M, Ariel N, Altboum Z, Kobiler D. 2005. Identification of strain specific markers in Bacillus anthracis by random amplification of polymorphic DNA. FEMS Microbiol. Lett. 244:199 -205.
25. Levy H, et al. 2011. Lethal factor is not required for Bacillus anthracis virulence in guinea pigs and rabbits. Microb. Pathog. 51:345-371.
26. Levy H, et al. 2012. The effect of deletion of the edema factor on Bacillus anthracis pathogenicity in guinea pigs and rabbits. Microb. Pathog. 52:55- 60.
27. Little SF, Knudson GB. 1986. Comparative efficacy of Bacillus anthracis live spore vaccine and protective antigen vaccine against anthrax in the guinea pig. Infect. Immun. 52:4.
28. Moayeri M, Haines D, Hyoung Leppla SH. 2003. Bacillus anthracis lethal toxin induces TNF-alpha-dependent hypoxia-mediated toxicity in mice. J. Clin. Invest. 112:670-682.
29. Moayeri M, Leppla SH. 2009. Cellular and systemic effects of anthrax lethal toxin and edema toxin. Mol. Aspects Med. 30:439-455.
30. Okinaka R, et al. 1999. Sequence, assembly and analysis of pXO1 and pXO2. J. Appl. Microbiol. 87:261-262.
31. Perego M, Hoch J. 2008. Commingling regulatory systems following acquisition of virulence plasmids by Bacillus anthracis. Trends Microbiol. 16:215-221.
32. Pezard C, Berche P, Mock M. 1991. Contribution of individual toxin components to virulence of Bacillus anthracis. Infect. Immun. 59:3472- 3477.
33. Pezard C, Weber M, Sirard JC, Berche P, Mock M. 1995. Protective immunity induced by Bacillus anthracis toxin-deficient strains. Infect. Immun. 63:1369 -1372.
34. Reed LJ, Muench H. 1938. A simple method of estimating fifty per cent endpoints. Am. J. Hyg. (Lond.) 27:493- 497.
35. Sambrook J, Fritsch EF, Maniatis T. 1989. Molecular cloning: a laboratory manual, 2nd ed. Laboratory Press, Cold Spring Harbor, NY.
36. Shafferman A, et al. 2010. Reverse vaccinology in Bacillus anthracis, p 295-306. In Shafferman A, Ordentlich A, Velan B (ed), The challenge of highly pathogenic microorganisms, mechanisms of virulence and novel medical countermeasures. Springer, London, United Kingdom.
37. Smith H. 2002. Discovery of the anthrax toxin: the beginning of studies of virulence determinants regulated in vivo. Int. J. Med. Microbiol. 291:411- 417.
38. Tang W-J, Guo Q. 2009. The adenylyl cyclase activity of anthrax edema factor. Mol. Aspects Med. 30:423- 430.
39. Tonello F, Montecucco C. 2009. The anthrax lethal factor and its MAPK kinase-specific metalloprotease activity. Mol. Aspects Med. 30:431- 438.
40. Tournier J-N, Rossi Paccani S, Quesnel-Hellmann A, Baldari CT. 2009. Anthrax toxins: a weapon to systematically dismantle the host immune defenses. Mol. Aspects Med. 30:456-466.
41. Welkos S, Vietri NJ, Gibbs PH. 1993. Non-toxigenic derivates of the Ames strain of Bacillus anthracis are fully virulent for mice: role of plasmid pXO2 and chromosome in strain-depended virulence. Microb. Pathog. 14:381-388.
42. Welkos SL, Marrero R. 1996. Pathogenesis and host resistance to infection: a model system and analysis of capsule synthesis and regulation by Bacillus anthracis. CRC Press, Boca Raton, FL.